Abstract
Postoperative adhesion (POA) is a serious event that always causes chronic pain and functional obstruction. Up to now, a variety of matrices prepared by diverse technologies have been employed as the physical barriers to prevent POA. Among them, the electrospun fibers of biodegradable polymers exhibit more obvious advantages, such as large surface area, high porosity, and excellent anti-adhesion efficiency. However, the pure electrospun fibers for anti-adhesion cannot effectively regulate the cellular behaviors, and tissue inflammation and healing. In recent years, the polymeric electrospun fibers loaded with various drugs, such as antimicrobial agents, antiinflammatory drugs, and healing accelerators, have been developed. The advanced anti-adhesion fibers play a more efficient role in the field of anti-adhesion, which can efficiently prevent POA and infection, tamp down inflammation, and promote the recovery of tissue function after surgery. This review highlights the recent development of anti-adhesion electrospun fibers loaded with various drugs, and presents the possible prospects.
Keywords: Anti-adhesion, antimicrobial agents, anti-inflammatory drugs, electrospun fibers, function recovery, healing accelerators, microscale, nanoscale.
Current Pharmaceutical Design
Title:Drug-Incorporated Electrospun Fibers Efficiently Prevent Postoperative Adhesion
Volume: 21 Issue: 15
Author(s): Bo Shi, Jianxun Ding, Junchao Wei, Changfeng Fu, Xiuli Zhuang and Xuesi Chen
Affiliation:
Keywords: Anti-adhesion, antimicrobial agents, anti-inflammatory drugs, electrospun fibers, function recovery, healing accelerators, microscale, nanoscale.
Abstract: Postoperative adhesion (POA) is a serious event that always causes chronic pain and functional obstruction. Up to now, a variety of matrices prepared by diverse technologies have been employed as the physical barriers to prevent POA. Among them, the electrospun fibers of biodegradable polymers exhibit more obvious advantages, such as large surface area, high porosity, and excellent anti-adhesion efficiency. However, the pure electrospun fibers for anti-adhesion cannot effectively regulate the cellular behaviors, and tissue inflammation and healing. In recent years, the polymeric electrospun fibers loaded with various drugs, such as antimicrobial agents, antiinflammatory drugs, and healing accelerators, have been developed. The advanced anti-adhesion fibers play a more efficient role in the field of anti-adhesion, which can efficiently prevent POA and infection, tamp down inflammation, and promote the recovery of tissue function after surgery. This review highlights the recent development of anti-adhesion electrospun fibers loaded with various drugs, and presents the possible prospects.
Export Options
About this article
Cite this article as:
Shi Bo, Ding Jianxun, Wei Junchao, Fu Changfeng, Zhuang Xiuli and Chen Xuesi, Drug-Incorporated Electrospun Fibers Efficiently Prevent Postoperative Adhesion, Current Pharmaceutical Design 2015; 21 (15) . https://dx.doi.org/10.2174/1381612821666150302152420
DOI https://dx.doi.org/10.2174/1381612821666150302152420 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements